Menu
Have questions about SeaStar Medical’s revolutionary Selective Cytopheretic Device (SCD)? Interested in SCD clinical trials? Want to become an investor or partner with a company that is passionate about advancing the critical-care paradigm and has the product to do it? Then just complete the form below, and we’ll be in touch!
SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. It is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
©SeaStar Medical 2023